Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GNMSF - Genmab A/S (GMAB) CEO Jan van de Winkel on Q2 2021 Results - Earnings Call Transcript

GNMSF - Genmab A/S (GMAB) CEO Jan van de Winkel on Q2 2021 Results - Earnings Call Transcript

Genmab A/S Dkk
Genmab A/S (GMAB) Q2 2021 Results Conference Call August 11, 2021 12:00 PM ET Company Participants Jan van de Winkel - President and CEO Anthony Pagano - CFO Judith Klimovsky - Chief Development Officer Anthony Mancini - COO Tahi Ahmadi - Chief Medical Officer Conference Call Participants Wimal Kapadia - Bernstein Elizabeth Walton - Credit Suisse Emily Field - Barclays James Gordon - JP Morgan Michael Novod - Nordea Michael Schmidt - Guggenheim Securities Graig Suvannavejh - Goldman Sachs Jonathan Chang - SVB Leerink Asthika Goonewardene - Truist Securities Kennen MacKay - RBC Presentation Operator Hello, and welcome to the Genmab Q2 2021 Conference Call. Throughout the call, all participants will be in a listen-only mode, and afterwards there still be a question-and-answer session. Just to remind you, this conference call is being recorded. During this telephone conference, you may be presented with forward-looking statements that include words such as

For further details see:

Genmab A/S (GMAB) CEO Jan van de Winkel on Q2 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Genmab A/S Dkk
Stock Symbol: GNMSF
Market: OTC
Website: genmab.com
Menu
GNMSF GNMSF Quote GNMSF Short GNMSF News GNMSF Articles GNMSF Message Board
Get GNMSF Alerts

News, Short Squeeze, Breakout and More Instantly...